Ascletis Pharma Inc - ESG Rating & Company Profile powered by AI
This report of Ascletis Pharma Inc is assembled by All Street Sevva using advanced NLP. Other companies in the rating industry group for Ascletis Pharma Inc are displayedin the table. The webpage contains a Q&A section on Ascletis Pharma Inc.
Ascletis Pharma Inc in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 3.3; made up of an environmental score of 2.0, social score of 3.2 and governance score of 4.8.
3.3
Low ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Caladrius Biosciences Inc | 8.0 | High |
| 1 | Can Fite Biopharma Ltd | 8.0 | High |
| ... | ... | ... | |
| 1234 | Quanterix Corp | 3.4 | Medium |
| 1234 | X4 Pharmaceuticals Inc | 3.4 | Medium |
| 1253 | Ascletis Pharma Inc | 3.3 | Medium |
| 1253 | Calithera Biosciences Inc | 3.3 | Medium |
| 1253 | Cara Therapeutics Inc | 3.3 | Medium |
| ... | ... | ... | |
| 1970 | Zyden Gentec Ltd | 0.0 | Low |
| 1970 | iNtRON Biotechnology Inc | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does Ascletis Pharma Inc have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes Ascletis Pharma Inc disclose current and historical energy intensity?
Sign up for free to unlockDoes Ascletis Pharma Inc report the average age of the workforce?
Sign up for free to unlockDoes Ascletis Pharma Inc reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes Ascletis Pharma Inc disclose its ethnicity pay gap?
Sign up for free to unlockDoes Ascletis Pharma Inc disclose cybersecurity risks?
Sign up for free to unlockDoes Ascletis Pharma Inc offer flexible work?
Sign up for free to unlockDoes Ascletis Pharma Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes Ascletis Pharma Inc disclose the number of employees in R&D functions?
Sign up for free to unlockDoes Ascletis Pharma Inc conduct supply chain audits?
Sign up for free to unlockDoes Ascletis Pharma Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes Ascletis Pharma Inc conduct 360 degree staff reviews?
Sign up for free to unlockDoes Ascletis Pharma Inc disclose the individual responsible for D&I?
Sign up for free to unlockDoes Ascletis Pharma Inc disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes Ascletis Pharma Inc disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes Ascletis Pharma Inc disclose water use targets?
Sign up for free to unlockDoes Ascletis Pharma Inc have careers partnerships with academic institutions?
Sign up for free to unlockDid Ascletis Pharma Inc have a product recall in the last two years?
Sign up for free to unlockDoes Ascletis Pharma Inc disclose incidents of discrimination?
Sign up for free to unlockDoes Ascletis Pharma Inc allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas Ascletis Pharma Inc issued a profit warning in the past 24 months?
Sign up for free to unlockDoes Ascletis Pharma Inc disclose parental leave metrics?
Sign up for free to unlockDoes Ascletis Pharma Inc disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes Ascletis Pharma Inc disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes Ascletis Pharma Inc disclose the pay ratio of women to men?
Sign up for free to unlockDoes Ascletis Pharma Inc support suppliers with sustainability related research and development?
Sign up for free to unlockDoes Ascletis Pharma Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes Ascletis Pharma Inc reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs Ascletis Pharma Inc involved in embryonic stem cell research?
Sign up for free to unlockDoes Ascletis Pharma Inc disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes Ascletis Pharma Inc disclose its waste policy?
Sign up for free to unlockDoes Ascletis Pharma Inc report according to TCFD requirements?
Sign up for free to unlockDoes Ascletis Pharma Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes Ascletis Pharma Inc disclose energy use targets?
Sign up for free to unlockDoes Ascletis Pharma Inc disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes Ascletis Pharma Inc have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for Ascletis Pharma Inc
These potential risks are based on the size, segment and geographies of the company.
Ascletis Pharma Inc., a biotechnology company, engages in the research and development, manufacture, marketing, and sale of pharmaceutical products in Mainland China and internationally. The company offers Ritonavir oral tablet, a pharmacokinetic booster of various oral antiviral drugs targeting viral proteases and a component of the approved oral antiviral drug Paxlovid; ASCLEVIR and GANOVO for the treatment of Hepatitis C virus. It is also developing ASC22 for treating chronic hepatitis B (CHB) and human immunodeficiency virus functional cure; ASC42 for chronic hepatitis B functional cure; ASC10 and ASC11 to treat COVID-19; ASC40, ASC41, ASC42, ASC43F FDC, ASC44F FDC, and ASC45F FDC for non-alcoholic steatohepatitis; and ASC42 for the treatment of primary biliary cholangitis. In addition, the company is developing ASC40 to treat recurrent glioblastoma, drug resistant breast cancer, and KRAS mutant non-small cell lung cancer; ASC61 and ASC63 for advanced solid tumors; ASC60 to treat solid tumors; and ASC40 for the treatment of acne, Ascletis Pharma Inc. was founded in 2013 and is headquartered in Hangzhou, the People's Republic of China.